Acción OMND OPTIMIND PHARMA CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Optimind Pharma Corp.

Acciones

OMND

CA68405U1012

Mercado cerrado - Canadian Securities Exchange
Otros sitios de cotización
 21:09:39 03/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,005 CAD -50,00 % Gráfico intradía de Optimind Pharma Corp. -50,00 % 0,00 %
10/01 Optimind Pharma Corp. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de noviembre de 2023 CI
08/01 Optimind Pharma Corp. anuncia cambios ejecutivos CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Optimind Pharma Reaches Agreement On Debenture Conversion
Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023
Optimind Pharma Corp. Announces Executive Changes
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended May 31, 2023
Optimind Pharma Corp. Auditor Raises 'Going Concern' Doubt
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 28, 2023
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy
Optimind Pharma Corp. acquired MindSetting Inc. from Beatrice Society Inc. for CAD 1.6 million.
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Optimind Pharma Corp. Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma Corporation
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
Optimind Pharma Inc. completed the acquisition of Loon Energy Corporation (TSXV:LNE.H) in a reverse merger transaction.
Optimind Pharma Corp. announced that it has received CAD 0.507 million in funding
Optimind Pharma Inc. entered into a letter of intent to acquire Loon Energy Corporation (TSXV:LNE.H) for CAD 8.3 million in a reverse merger transaction.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción OMND
  4. Noticias Optimind Pharma Corp.
  5. Otros idiomas